HTGMQ vs. KLDO, VIVE, VRAYQ, NOVNQ, IDXG, PRPO, TBIO, CHEK, PMD, and TLIS
Should you be buying HTG Molecular Diagnostics stock or one of its competitors? The main competitors of HTG Molecular Diagnostics include Kaleido Biosciences (KLDO), Viveve Medical (VIVE), ViewRay (VRAYQ), NVN Liquidation (NOVNQ), Interpace Biosciences (IDXG), Precipio (PRPO), Telesis Bio (TBIO), Check-Cap (CHEK), Psychemedics (PMD), and Talis Biomedical (TLIS). These companies are all part of the "medical" sector.
Kaleido Biosciences (NASDAQ:KLDO) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.
Kaleido Biosciences received 54 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.
HTG Molecular Diagnostics has higher revenue and earnings than Kaleido Biosciences.
In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled Kaleido Biosciences'average media sentiment score.
81.6% of Kaleido Biosciences shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by company insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Kaleido Biosciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, HTG Molecular Diagnostics has a beta of 2.97, meaning that its stock price is 197% more volatile than the S&P 500.
Summary
Kaleido Biosciences and HTG Molecular Diagnostics tied by winning 3 of the 6 factors compared between the two stocks.
Get HTG Molecular Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HTGMQ vs. The Competition
HTG Molecular Diagnostics Competitors List
Related Companies and Tools
